Suppr超能文献

[肿瘤异质性的识别与管理进展]

[Advances on Recognizing and Managing Tumor Heterogeneity].

作者信息

Zhong Rui, Li Hui, Zhang Shuang, Liu Jingjing, Cheng Ying

机构信息

Medical Oncology Translational Research Lab, Jilin Provincial Cancer Hospital, Changchun 130012, China.

Department of Toracic Oncology, Jilin Provincial Cancer Hospital, Changchun 130012, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2018 Sep 20;21(9):712-718. doi: 10.3779/j.issn.1009-3419.2018.09.11.

Abstract

Tumor heterogeneity is one of the characteristics of malignant tumors, which can cause differences in tumor growth rate, invasion, migration, drug sensitivity and prognosis. Discoveries and development upon on tumor-driver genes and targeted therapy paved the way on dealing with cancer diagnosis and treatment. However, the existence of tumor heterogeneity makes malignant tumor more hardly to overcome. It is generally present and far more complicated during the process of cancer recurrence, development and evolution. Thus, it has becoming key areas in precision medicine regarding to designing optimal therapeutic approaches targeting the mechanisms and phenotypes of tumor heterogeneity, based on novel detecting techniques and new concepts and theory. This review summarized the current references on tumor heterogeneity, in order to better understand the function and mechanisms, and eventually manage tumor heterogeneity through various methods.
.

摘要

肿瘤异质性是恶性肿瘤的特征之一,可导致肿瘤生长速度、侵袭、迁移、药物敏感性和预后的差异。肿瘤驱动基因和靶向治疗的发现与发展为癌症的诊断和治疗铺平了道路。然而,肿瘤异质性的存在使恶性肿瘤更难攻克。它普遍存在,并且在癌症复发、发展和演变过程中更为复杂。因此,基于新的检测技术、新的概念和理论,针对肿瘤异质性的机制和表型设计最佳治疗方法已成为精准医学的关键领域。这篇综述总结了当前关于肿瘤异质性的参考文献,以便更好地理解其功能和机制,并最终通过各种方法应对肿瘤异质性。

相似文献

1
[Advances on Recognizing and Managing Tumor Heterogeneity].[肿瘤异质性的识别与管理进展]
Zhongguo Fei Ai Za Zhi. 2018 Sep 20;21(9):712-718. doi: 10.3779/j.issn.1009-3419.2018.09.11.
4
The challenges of tumor genetic diversity.肿瘤基因多样性的挑战。
Cancer. 2017 May 15;123(6):917-927. doi: 10.1002/cncr.30430. Epub 2016 Nov 8.
7
Tumor heterogeneity: does it matter?肿瘤异质性:它重要吗?
Expert Rev Anticancer Ther. 2019 Oct;19(10):857-867. doi: 10.1080/14737140.2019.1667236. Epub 2019 Sep 24.
9
Intratumoral heterogeneity and consequences for targeted therapies.肿瘤内异质性及其对靶向治疗的影响。
Bull Cancer. 2015 Jan;102(1):17-23. doi: 10.1016/j.bulcan.2014.12.006. Epub 2015 Jan 2.
10
Cellular heterogeneity and molecular evolution in cancer.肿瘤中的细胞异质性和分子进化。
Annu Rev Pathol. 2013 Jan 24;8:277-302. doi: 10.1146/annurev-pathol-020712-163923. Epub 2012 Oct 22.

本文引用的文献

4
Tracking the Evolution of Non-Small-Cell Lung Cancer.跟踪非小细胞肺癌的演变。
N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26.
7
Clonal evolution of chemotherapy-resistant urothelial carcinoma.化疗耐药性尿路上皮癌的克隆进化
Nat Genet. 2016 Dec;48(12):1490-1499. doi: 10.1038/ng.3692. Epub 2016 Oct 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验